These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29981879)

  • 1. A subtype-specific neuropeptide FF receptor antagonist attenuates morphine and nicotine withdrawal syndrome in the rat.
    Malin DH; Henceroth MM; Elayoubi J; Campbell JR; Anderson A; Goyarzu P; Izygon J; Madison CA; Ward CP; Burstein ES
    Neurosci Lett; 2018 Sep; 684():98-103. PubMed ID: 29981879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of morphine tolerance by a compound with NPFF receptor subtype-selective actions.
    Malin DH; Henceroth MM; Izygon JJ; Nghiem DM; Moon WD; Anderson AP; Madison CA; Goyarzu P; Ma JN; Burstein ES
    Neurosci Lett; 2015 Jan; 584():141-5. PubMed ID: 25459291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.
    Elhabazi K; Trigo JM; Mollereau C; Moulédous L; Zajac JM; Bihel F; Schmitt M; Bourguignon JJ; Meziane H; Petit-demoulière B; Bockel F; Maldonado R; Simonin F
    Br J Pharmacol; 2012 Jan; 165(2):424-35. PubMed ID: 21718302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF.
    Malin DH; Lake JR; Short PE; Blossman JB; Lawless BA; Schopen CK; Sailer EE; Burgess K; Wilson OB
    Pharmacol Biochem Behav; 1996 Jul; 54(3):581-5. PubMed ID: 8743632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of naloxone-precipitated morphine withdrawal syndromes in rats by neuropeptide FF analogs.
    Tan PP; Chen JC; Li JY; Liang KW; Wong CH; Huang EY
    Peptides; 1999; 20(10):1211-7. PubMed ID: 10573293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone precipitates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Carter VA; Cunningham JS; Wilson OB
    Psychopharmacology (Berl); 1993; 112(2-3):339-42. PubMed ID: 7871039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of neuropeptide FF neurons in the brainstem nucleus tractus solitarius following cardiovascular challenge and opiate withdrawal.
    Jhamandas JH; Harris KH; Petrov T; Yang HY; Jhamandas KH
    J Comp Neurol; 1998 Dec; 402(2):210-21. PubMed ID: 9845244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin A (2-17) attenuates the unconditioned but not the conditioned effects of opiate withdrawal in the rat.
    Shippenberg TS; Funada M; Schutz CG
    Psychopharmacology (Berl); 2000 Sep; 151(4):351-8. PubMed ID: 11026742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive immunization against nicotine attenuates somatic nicotine withdrawal syndrome in the rat.
    Malin DH; Moon WD; Goyarzu P; Magallanes N; Blair MB; Alexander MR; McDavid L; Spurgeon JL; Ennifar S; Fattom A
    Nicotine Tob Res; 2010 Apr; 12(4):438-44. PubMed ID: 20203107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment.
    Stinus L; Allard M; Gold L; Simonnet G
    Peptides; 1995; 16(7):1235-41. PubMed ID: 8545244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male rats.
    Ayoub SM; Smoum R; Farag M; Atwal H; Collins SA; Rock EM; Limebeer CL; Piscitelli F; Iannotti FA; Lichtman AH; Leri F; Di Marzo V; Mechoulam R; Parker LA
    Psychopharmacology (Berl); 2020 Sep; 237(9):2753-2765. PubMed ID: 32556401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.
    Paterson NE; Markou A
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):64-72. PubMed ID: 14712336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurosteroids in nicotine and morphine dependence.
    Concas A; Sogliano C; Porcu P; Marra C; Brundu A; Biggio G
    Psychopharmacology (Berl); 2006 Jun; 186(3):281-92. PubMed ID: 16133140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects.
    Watkins SS; Stinus L; Koob GF; Markou A
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1053-64. PubMed ID: 10688623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia.
    Harris AC; Rothwell PE; Gewirtz JC
    Psychopharmacology (Berl); 2008 Mar; 196(4):649-60. PubMed ID: 18026718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT; Little PJ; Kuhn CM
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome.
    Malin DH; Lake JR; Arcangeli KR; Deshotel KD; Hausam DD; Witherspoon WE; Carter VA; Yang HY; Pal B; Burgess K
    Life Sci; 1993; 53(17):PL261-6. PubMed ID: 8412495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists.
    Quelven I; Roussin A; Zajac JM
    Eur J Pharmacol; 2005 Jan; 508(1-3):107-14. PubMed ID: 15680260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.